News Medical on MSN20h
AI platform identifies which patients are likely to benefit most from a cancer clinical trialA study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in ...
In a study published today in the Journal of Clinical Investigation, Fred Hutch Cancer Center cancer chemical biologist ...
GlobalData on MSN17h
Contineum concludes enrolment in Phase II multiple sclerosis therapy trialContineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...
For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...
Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
David Walt, the HMS Hansjörg Wyss Professor of Biologically Inspired Engineering and professor of pathology at Brigham and Women’s Hospital, was awarded the National Medal of Technology and Innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback